Morgan Stanley (ZEPP) units disclose 8.8% beneficial stake in Zepp Health shares

Rhea-AI Filing Summary

Morgan Stanley and Morgan Stanley Capital Services LLC report beneficial ownership of Zepp Health Corp Class A Ordinary Shares / American Depositary Receipts on an amended Schedule 13G. The firms report 11,869,344 shares with shared voting and shared dispositive power, representing 8.8% of the class as of June 30, 2026. They report no sole voting or dispositive power, and clarify that the filing only reflects holdings of specified Morgan Stanley reporting units, not all affiliates.

Key Figures

Beneficially owned shares: 11,869,344 shares Ownership percentage: 8.8% Sole voting power: 0 shares +4 more

7 metrics

Beneficially owned shares 11,869,344 shares Class A Ordinary Shares / ADRs beneficially owned by Morgan Stanley entities

Ownership percentage 8.8% Percent of Zepp Health Corp Class A Ordinary Shares / ADRs

Sole voting power 0 shares Shares over which filers have sole power to vote

Shared voting power 11,869,344 shares Shares over which filers have shared power to vote

Sole dispositive power 0 shares Shares over which filers have sole dispositive power

Shared dispositive power 11,869,344 shares Shares over which filers have shared dispositive power

Reporting date 06/30/2026 Date for which the ownership information is reported

Key Terms

beneficially owned, shared voting power, shared dispositive power, parent holding company, +1 more

5 terms

beneficially owned financial

"this filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

shared voting power financial

"Shared Voting Power 11,869,344.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power financial

"Shared Dispositive Power 11,869,344.00"

parent holding company regulatory

"If a parent holding company has filed this schedule, pursuant to (ii)(G)"

Item 7 Information regulatory

"99.2 Item 7 Information"

FAQ

What stake does Morgan Stanley report in Zepp Health Corp (ZEPP)?

Morgan Stanley and Morgan Stanley Capital Services LLC report beneficial ownership of 11,869,344 Zepp Health shares, representing 8.8% of the outstanding Class A Ordinary Shares / ADRs as of June 30, 2026, with shared voting and dispositive power.

Which entities are filing the Schedule 13G/A related to ZEPP?

The Schedule 13G/A is filed by Morgan Stanley and Morgan Stanley Capital Services LLC, both organized in Delaware, with principal offices at 1585 Broadway, New York, NY 10036, reporting a shared 8.8% beneficial ownership stake in Zepp Health.

How much voting power does Morgan Stanley report for ZEPP shares?

The filers report 0 shares with sole voting power and 11,869,344 shares with shared voting power in Zepp Health Corp Class A Ordinary Shares / ADRs, reflecting coordinated control over this 8.8% stake among specified Morgan Stanley units.

What dispositive power does Morgan Stanley have over its ZEPP position?

Morgan Stanley and its affiliate report 0 shares with sole dispositive power and 11,869,344 shares with shared dispositive power in Zepp Health. This means decisions to sell or otherwise dispose are shared among the reporting units identified in the filing.

Does the ZEPP Schedule 13G/A cover all Morgan Stanley affiliates?

No. The filing states it reflects securities beneficially owned, or deemed beneficially owned, by certain Morgan Stanley reporting units only, and does not include any securities held by other operating units whose ownership is disaggregated under SEC Release No. 34-39538.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 04:20 PM Accepted by SEC EDGAR 08/13/2026 - 04:19 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Zepp Health Corp

(Name of Issuer)

Class A Ordinary Shares / American Depositary Receipts

(Title of Class of Securities)

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP No.

1

Names of Reporting Persons

Morgan Stanley

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 11,869,344.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 11,869,344.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

11,869,344.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.8 %

12

Type of Reporting Person (See Instructions)

HC, CO

SCHEDULE 13G

CUSIP No.

1

Names of Reporting Persons

Morgan Stanley Capital Services LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 11,869,344.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 11,869,344.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

11,869,344.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.8 %

12

Type of Reporting Person (See Instructions)

BD, CO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Zepp Health Corp
(b)	Address of issuer's principal executive offices: BUILDING B2, ZHONG'AN CHUANGGU, TECHNOLOGY PARK NO.900 WANGJIANG WEST RD, HEFEI, F4, 230088
Item 2.
(a)	Name of person filing: 1: Morgan Stanley 2: Morgan Stanley Capital Services LLC
(b)	Address or principal business office or, if none, residence: 1: 1585 Broadway, New York, NY 10036 ;2: 1585 Broadway, New York, NY 10036
(c)	Citizenship: 1: Delaware 2: Delaware
(d)	Title of class of securities: Class A Ordinary Shares / American Depositary Receipts
(e)	CUSIP No.:
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See the response(s) to Item 9 on the attached cover page(s).
(b)	Percent of class: 8.8 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See the response(s) to Item 5 on the attached cover page(s).
	(ii) Shared power to vote or to direct the vote: See the response(s) to Item 6 on the attached cover page(s).
	(iii) Sole power to dispose or to direct the disposition of: See the response(s) to Item 7 on the attached cover page(s).
	(iv) Shared power to dispose or to direct the disposition of: See the response(s) to Item 8 on the attached cover page(s).
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit 99.2
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. * In Accordance with the Securities and Exchange Commission Release No. 34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by certain operating units (collectively, the "MS Reporting Units") of Morgan Stanley and its subsidiaries and affiliates (collectively, "MS"). This filing does not reflect securities, if any, beneficially owned by any operating units of MS whose ownership of securities is disaggregated from that of the MS Reporting Units in accordance with the Release.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Morgan Stanley

Signature:	Claire Gordon
Name/Title:	Authorized Signatory, Morgan Stanley
Date:	08/12/2026

Morgan Stanley Capital Services LLC

Signature:	Claire Gordon
Name/Title:	Authorized Signatory, Morgan Stanley Capital Services LLC
Date:	08/12/2026

Exhibit Information

EXHIBIT NO. EXHIBITS ------------------ ------------------------------------ 99.1 Joint Filing Agreement 99.2 Item 7 Information * Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001).